Autumn Soucy

Goodwin

Contact
View Bio
RSS

Latest Posts › Life Sciences

Share:

Parties in Amgen v. Hospira Pegfilgrastim Litigation Stipulate to Dismissal of All Claims

On March 19, 2022, the parties in the Amgen Inc. v. Hospira Inc. (D. Del., No. 20-201) NEULASTA®/pegfilgrastim litigation submitted a stipulation to dismiss all claims and counterclaims in the litigation with prejudice. The...more

3/22/2022  /  Biologics , Biosimilars , FDA Approval , Food and Drug Administration (FDA) , Life Sciences , Pharmaceutical Industry , Pharmaceutical Patents
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide